Physician

Jose F. Roldan, MD,MS

According to 2025 Medicare claims, Jose Roldan, MD, MS (NPI: 1285644427) practices rheumatology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is ARTHRITIS ASSOCIATES, P.A. (NPI: 1689729295; TIN: 562613565) and primary practice location at 78229-2449. Roldan is affiliated with the Main Street Rural Health Hickory ACO LLC (ACO ID: A5334) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Roldan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 739 traditional Medicare patients, billed 199,015 HCPCS/CPT codes, and received $2,557,964 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,654 prescription claims across 822 beneficiaries totaling $5,832,452 in drug costs, led by Humira(Cf) Pen (Adalimumab). 2016 DME data shows 12 claims. Open Payments data shows 87 records totaling $948. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $762,565 to $2,557,964. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,493,176 to $5,832,452. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	506	57,287	$762,565
2016	510	62,276	$888,798
2017	516	59,522	$847,280
2018	529	58,087	$890,462
2019	581	91,329	$1,176,620
2020	625	131,647	$1,380,582
2021	678	141,217	$1,753,013
2022	730	171,973	$2,204,330
2023	773	198,563	$2,449,804
2024	739	199,015	$2,557,964

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	393	3,300	$1,493,176
2016	399	3,094	$1,516,781
2017	423	3,185	$2,152,147
2018	492	3,570	$2,739,861
2019	574	4,107	$2,761,226
2020	562	4,294	$2,732,301
2021	589	3,810	$3,495,737
2022	703	3,740	$4,198,211
2023	760	3,888	$5,101,423
2024	822	4,654	$5,832,452

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	12	$192
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	695	1,852	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	526	904	$11
36415	Insertion of needle into vein for collection of blood sample	526	1,362	$6
86140	Measurement c-reactive protein for detection of infection or inflammation	468	1,151	$5
85651	Red blood cell sedimentation rate, to detect inflammation, non-automated	468	1,152	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	121	3,416	$902,274
Enbrel Sureclick	Etanercept	74	2,240	$718,007
Orencia Clickject	Abatacept	110	3,196	$665,671
Rinvoq	Upadacitinib	83	2,881	$586,774
Skyrizi Pen	Risankizumab-Rzaa	20	1,568	$417,001

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	87	$948	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Jose F. Roldan, MD, MS?

Tedicare shows public-source Medicare data for Jose F. Roldan, MD, MS (NPI 1285644427), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jose F. Roldan, MD, MS have ACO affiliation data?

Jose F. Roldan, MD, MS is shown with ACO affiliation data for Main Street Rural Health Hickory ACO LLC (MSSP, ACO ID A5334) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Jose F. Roldan, MD, MS?

Jose F. Roldan, MD, MS is linked to ARTHRITIS ASSOCIATES, P.A. (billing NPI 1689729295) in the available physician profile data.

Does Jose F. Roldan, MD, MS have Open Payments data?

Jose F. Roldan, MD, MS has 87 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.